Marusan-Ai Co., Ltd. (XNGO:2551)
3,640.00
+20.00 (0.55%)
At close: May 9, 2025
Marusan-Ai Revenue
Marusan-Ai had revenue of 7.41B JPY in the quarter ending March 20, 2025, a decrease of -4.11%. This brings the company's revenue in the last twelve months to 33.20B, up 3.07% year-over-year. In the fiscal year ending September 20, 2024, Marusan-Ai had annual revenue of 33.16B with 7.13% growth.
Revenue (ttm)
33.20B
Revenue Growth
+3.07%
P/S Ratio
0.25
Revenue / Employee
74.78M
Employees
444
Market Cap
8.16B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Sep 20, 2024 | 33.16B | 2.21B | 7.13% |
Sep 20, 2023 | 30.95B | 251.00M | 0.82% |
Sep 20, 2022 | 30.70B | 608.00M | 2.02% |
Sep 20, 2021 | 30.09B | 625.00M | 2.12% |
Sep 20, 2020 | 29.47B | 2.09B | 7.65% |
Sep 20, 2019 | Pro | Pro | Pro |
Sep 20, 2018 | Pro | Pro | Pro |
Sep 20, 2017 | Pro | Pro | Pro |
Sep 20, 2016 | Pro | Pro | Pro |
Sep 20, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Toyota Motor | 48.04T |
Sony Group | 13.81T |
Mitsubishi UFJ Financial Group | 6,199.27B |
Hitachi | 9,783.37B |
Keyence | 1,059.15B |
Fast Retailing | 3,295.04B |
Nintendo | 1,164.92B |
Chugai Pharmaceutical | 1,222.12B |